A tumor cell exosome-mimicking multifunctional nanozyme for targeted breast cancer radiotherapy
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
A multifunctional nanozyme that mimics tumor cell exosomes (CuPy-Au@EM) was fabricated in this work for achieving a highly effective and secure cancer radiotherapy regimen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Together with advances in nanoparticle-mediated siRNA delivery, these findings suggest that biologically inspired delivery systems may further enhance the therapeutic potential of nucleic acid-based radiosensitization strategies by improving intracellular delivery, protecting RNA cargo from degradation, and reducing off-target effects [109,110,111].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [109]
Citations
Cites
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Breast Cancer Statistics, 2022
Giaquinto, A. N., Sung, H., Miller, K. D., Kramer, J. L., Newman, L. A., Minihan, A., Jemal, A., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21754 · Cited by 2,286
Cell-programmed nutrient partitioning in the tumour microenvironment
Reinfeld, B. I., Madden, M. Z., Wolf, M. M., Chytil, A., Bader, J. E., Patterson, A. R., Sugiura, A., Cohen, A. S., Ali, A., Do, B. T., et al. (2021) · Nature · doi:10.1038/s41586-021-03442-1 · Cited by 1,023
Efficient RNA drug delivery using red blood cell extracellular vesicles
Usman, W. M., Pham, T. C., Kwok, Y. Y., Vu, L. T., Ma, V., Peng, B., Chan, Y. S., Wei, L., Chin, S. M., Azad, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04791-8 · Cited by 663
Wang, Z., Zhang, Y., Ju, E., Liu, Z., Cao, F., Chen, Z., Ren, J., & Qu, X. (2018) · Nature Communications · doi:10.1038/s41467-018-05798-x · Cited by 643
Sang, Y., Cao, F., Li, W., Zhang, L., You, Y., Deng, Q., Dong, K., Ren, J., & Qu, X. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b12873 · Cited by 591
Langendijk, J. A., Lambin, P., De Ruysscher, D., Widder, J., Bos, M., & Verheij, M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.05.007 · Cited by 549
Application of Radiosensitizers in Cancer Radiotherapy
Gong, L., Zhang, Y., Liu, C., Zhang, M., & Han, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s290438 · Cited by 479
Noh, J., Kwon, B., Han, E., Park, M., Yang, W., Cho, W., Yoo, W., Khang, G., & Lee, D. (2015) · Nature Communications · doi:10.1038/ncomms7907 · Cited by 461
Mito‐Bomb: Targeting Mitochondria for Cancer Therapy
Guo, X., Yang, N., Ji, W., Zhang, H., Dong, X., Zhou, Z., Li, L., Shen, H., Yao, S. Q., & Huang, W. (2021) · Advanced Materials · doi:10.1002/adma.202007778 · Cited by 421
Cited by
Fu, Q., Wei, C., & Wang, M. (2024) · ACS Nano · doi:10.1021/acsnano.4c02265 · Cited by 196
Rational Design of Nanozymes for Engineered Cascade Catalytic Cancer Therapy
Jia, X., Wang, E., & Wang, J. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00882 · Cited by 167
Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade
Moghassemi, S., Dadashzadeh, A., Sousa, M. J., Vlieghe, H., Yang, J., León-Félix, C. M., & Amorim, C. A. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.02.021 · Cited by 148
“Doxorubicin, a commonly used drug for treating solid tumors [229], has been loaded into exosomes as a potential treatment for different cancer types, including osteosarcoma [175,230,231], colon cancer [232,233], ovarian cancer [234,235], breast cancer [236 – 238], and pancreatic cancer [239,240].”
BackgroundZhang, N., Ping, W., Rao, K., Zhang, Z., Huang, R., Zhu, D., Li, G., & Ning, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.045 · Cited by 80
Self-citationTargeted delivery of nano-radiosensitizers for tumor radiotherapy
Shi, S., Zhong, H., Zhang, Y., & Mei, Q. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216101 · Cited by 45
Metadata
- Authors
- Chen, G., Jiang, D., Ding, S., Huang, C., Zhu, D., & Jiang, H.
- Affiliations
- Zhongnan Hospital of Wuhan University (CN)
- Jinan University (CN)
- Wuhan University (CN)
- Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Hubei Center of Quality Control for Radiotherapy of Cancer, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China
- Venue
- Nanoscale
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2023
- Volume
- 15
- Issue
- 36
- Pages
- 14949-14957
- ISSN
- 2040-3364 (ISSN-L)
- 2040-3372
- OpenAlex
- W4386346830
- Cited by
- 31
- References
- 40
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 6 · 2023: 2
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nanoscale (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wuhan University of Science and Technology (2019079)
- Zhongnan Hospital of Wuhan University (ZNXKPY2020012, PTXM2022012)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Materials Chemistry › Advanced Nanomaterials in Catalysis
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- nanozymes, multifunctional nanomaterials, breast cancer, radiotherapy, radiosensitizers, gold nanoparticles, targeted drug delivery, tumor cell proliferation
- MeSH terms
- Breast Neoplasms, Female, Gold, Humans, Hydrogen Peroxide, Cell Line, Tumor, Metal Nanoparticles, Exosomes, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A tumor cell exosome-mimicking multifunctional nanozyme for targeted breast cancer radiotherapy. https://app.cochat.ai/papers/10.1039/d3nr03065b
- The paper
- Chen, G., Jiang, D., Ding, S., Huang, C., Zhu, D., & Jiang, H. (2023). A tumor cell exosome-mimicking multifunctional nanozyme for targeted breast cancer radiotherapy. Nanoscale. https://doi.org/10.1039/d3nr03065b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.